A new analysis by Spherix Global Insights reveals that access barriers, not efficacy issues, are limiting Xphozah (tenapanor) uptake in the dialysis hyperphosphatemia market. Nephrologists report they would nearly triple Xphozah use without reimbursement and coverage obstacles. However, the drug faces persistence challenges with gastrointestinal tolerability causing discontinuation rates to double to 8%. The findings also show physicians significantly overestimate phosphorus control and combination therapy use among patients. As the TDAPA reimbursement program expires at the end of 2026, phosphate-lowering therapies will face a flattened competitive landscape.

The global urology devices market is valued at USD 39.23 billion in 2025 and is projected to reach USD 80.0 billion by 2035, growing at a CAGR of 7.35%. Growth is driven by rising demand for robotic-assisted surgery, kidney disease treatment, and minimally invasive procedures. North America leads the market while Asia Pacific records the fastest growth.

The U.S. arteriovenous fistula devices market is projected to grow from $112 million in 2025 to $120 million by 2033, driven by rising end-stage renal disease cases and increasing demand for advanced vascular access solutions.

Quest Diagnostics reported strong Q1 2025 results, with revenue and earnings beating estimates. The company reaffirmed its full-year guidance and announced strategic acquisitions and partnerships, fueling confidence in its outlook.

The global wearable artificial organs market is expected to grow significantly from $11.17 billion in 2024 to $64.19 billion by 2035, driven by government initiatives, technological advancements, and patient preference for non-invasive solutions. North America and Asia Pacific are expected to be the key growth regions.

The report provides a comprehensive analysis of the China infusion systems market, including infusion pumps and infusion pump disposables, with data from 2018 to 2033. It covers key market information, company profiles, pipeline products, and recent developments.

The U.S. compounding pharmacies market is expected to grow at a CAGR of 4.06% from 2023 to 2029, driven by the growing demand for compounded bioidentical menopausal hormone therapy among women and the increasing adoption of advanced technologies in the industry.

The global hemodialysis and peritoneal dialysis market is projected to reach a value of USD 142.97 Billion by 2031, growing at a CAGR of 6.5% during the forecast period. The increasing prevalence of chronic kidney disease and the need for innovative dialysis technologies are driving the market growth.

The global hemodialysis and peritoneal dialysis market is expected to reach a value of USD 142.97 Billion by 2031, driven by the increasing prevalence of chronic kidney disease and the need for innovative dialysis technologies.

The global medical specialty bags market is expected to reach a value of USD 14.56 Billion by 2031, driven by the rising prevalence of chronic diseases and the increasing demand for specialized care. The market is dominated by ostomy collection bags and hospitals, with North America leading the growth due to its advanced healthcare infrastructure.

The artificial organs market is expected to grow at a CAGR of 7.68% from 2024 to 2031, driven by the increasing demand for organ transplants and advancements in medical technologies. The mechanical artificial organs segment is expected to dominate the market due to their reliability, low risk of failure, and affordability.

The global blood recovery machine market is expected to grow at a CAGR of 5.9% from 2024 to 2033, driven by advancements in medical technologies, increased awareness of autologous blood transfusion benefits, and rising demand for surgical procedures.